Comparative biomarkers for HBsAg loss with antiviral therapy shows dominant influence of quantitative HBsAg (qHBsAg).
Lim SG, Phyo WW, Ling JZJ, Cloherty G, Butler EK, Kuhns MC, McNamara AL, Holzmayer V, Gersch J, Yang WL, Ngu JH, Chang J, Tan J, Ahmed T, Dan YY, Lee YM, Lee GH, Tan PS, Huang DQ, Khine HTW, Lee C, Tay A, Chan E.
Lim SG, et al. Among authors: mcnamara al.
Aliment Pharmacol Ther. 2021 Jan;53(1):172-182. doi: 10.1111/apt.16149. Epub 2020 Nov 7.
Aliment Pharmacol Ther. 2021.
PMID: 33159496
Clinical Trial.